Literature DB >> 21072553

Systemic lupus erythematosus, human papillomavirus infection, cervical pre-malignant and malignant lesions: a systematic review.

Iuri Usêda Santana1, Alline do Nascimento Gomes, Leomar D'Cirqueira Lyrio, Maria Fernanda Rios Grassi, Mittermayer Barreto Santiago.   

Abstract

The purpose of this study was to review and evaluate systematically the scientific evidence on the relationship between systemic lupus erythematosus (SLE), human papillomavirus (HPV) infection, pre-cancerous cervical abnormalities, and cervical cancer. Establishing strict inclusion and exclusion criteria, we performed an extensive search for studies in MEDLINE and BIREME databases to assess the studies that evaluated the frequency of HPV infection, pre-cancerous cervical abnormalities, and cervical cancer in women with SLE. Secondary references were additionally obtained from the included articles. Thirty-three articles met the criteria previously established. Fifteen out of 18 studies that performed cytological analysis showed a higher frequency of squamous intraepithelial lesions in SLE patients compared with normal women. Moreover, three studies found a higher frequency of high-grade squamous intraepithelial lesions. Additionally, it was observed that women with SLE had a higher frequency of HPV infection, confirmed by molecular biology techniques. Curiously, despite the above findings, no increased frequency of cervical cancer was observed in the majority of the studies which addressed this issue. Five studies observed a relationship between cervical abnormalities and previous use of immunosuppressive drugs. This review suggests that SLE patients seem not to be at increased risk for developing cervical cancer; however, they should be considered at higher risk for HPV infection and cervical dysplasia than the general population. Thus, gynecological visits at shorter intervals seem to be a reasonable approach for those patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21072553     DOI: 10.1007/s10067-010-1606-0

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  36 in total

Review 1.  The new H1N1 and HPV vaccines and old fears.

Authors:  Ari Balofsky; Nancy Agmon-Levin; Yehuda Shoenfeld
Journal:  Curr Opin Rheumatol       Date:  2010-07       Impact factor: 5.006

2.  Increased risk of cancer in patients with systemic lupus erythematosus.

Authors:  T Pettersson; E Pukkala; L Teppo; C Friman
Journal:  Ann Rheum Dis       Date:  1992-04       Impact factor: 19.103

3.  Increased prevalence of squamous intraepithelial lesions in systemic lupus erythematosus: association with human papillomavirus infection.

Authors:  Lai-Shan Tam; Alice Y K Chan; Paul K S Chan; Alexander R Chang; Edmund K Li
Journal:  Arthritis Rheum       Date:  2004-11

4.  Non-Hodgkin's lymphoma and other cancers among a cohort of patients with systemic lupus erythematosus.

Authors:  L Mellemkjaer; V Andersen; M S Linet; G Gridley; R Hoover; J H Olsen
Journal:  Arthritis Rheum       Date:  1997-04

5.  Is there an association of malignancy with systemic lupus erythematosus? An analysis of 276 patients under long-term review.

Authors:  S M Sultan; Y Ioannou; D A Isenberg
Journal:  Rheumatology (Oxford)       Date:  2000-10       Impact factor: 7.580

Review 6.  Human papillomavirus infection, cancer & therapy.

Authors:  Helena Sterlinko Grm; Martina Bergant; Lawrence Banks
Journal:  Indian J Med Res       Date:  2009-09       Impact factor: 2.375

7.  Increased cancer incidence in a Swedish cohort of patients with systemic lupus erythematosus.

Authors:  Lena Björnådal; Björn Löfström; Li Yin; Ingrid E Lundberg; Anders Ekbom
Journal:  Scand J Rheumatol       Date:  2002       Impact factor: 3.641

8.  Systemic lupus erythematosus: predisposition for uterine cervical dysplasia.

Authors:  Z Blumenfeld; M Lorber; N Yoffe; Y Scharf
Journal:  Lupus       Date:  1994-02       Impact factor: 2.911

9.  Frequency of neoplasia in systemic lupus erythematosus and rheumatoid arthritis.

Authors:  R B Lewis; C W Castor; R E Knisley; G G Bole
Journal:  Arthritis Rheum       Date:  1976 Nov-Dec

10.  Natural history of cervical papilloma virus infection in systemic lupus erythematosus - a prospective cohort study.

Authors:  Lai-Shan Tam; Paul K S Chan; Suzanne C Ho; May M Y Yu; So-Fan Yim; Tak-Hong Cheung; Martin C S Wong; Edmund K Li
Journal:  J Rheumatol       Date:  2009-12-23       Impact factor: 4.666

View more
  27 in total

1.  Risk of human papillomavirus infection in women with rheumatic disease: cervical cancer screening and prevention.

Authors:  Seoyoung C Kim; Sarah Feldman; Anna-Barbara Moscicki
Journal:  Rheumatology (Oxford)       Date:  2018-07-01       Impact factor: 7.580

2.  Human papillomavirus and chlamydia trachomatis infections in rheumatoid arthritis under anti-TNF therapy: an observational study.

Authors:  Mariana G Waisberg; Ana C M Ribeiro; Wellington M Candido; Poliana B Medeiros; Cezar N Matsuzaki; Mariana C Beldi; Maricy Tacla; Helio H Caiaffa-Filho; Eloísa Bonfa; Clovis A Silva
Journal:  Rheumatol Int       Date:  2014-10-28       Impact factor: 2.631

3.  Risk of high-grade cervical dysplasia and cervical cancer in women with systemic inflammatory diseases: a population-based cohort study.

Authors:  Seoyoung C Kim; Robert J Glynn; Edward Giovannucci; Sonia Hernández-Díaz; Jun Liu; Sarah Feldman; Elizabeth W Karlson; Sebastian Schneeweiss; Daniel H Solomon
Journal:  Ann Rheum Dis       Date:  2014-03-11       Impact factor: 19.103

Review 4.  A review on SLE and malignancy.

Authors:  May Y Choi; Kelsey Flood; Sasha Bernatsky; Rosalind Ramsey-Goldman; Ann E Clarke
Journal:  Best Pract Res Clin Rheumatol       Date:  2017-11-10       Impact factor: 4.098

5.  Biologic Disease-Modifying Antirheumatic Drugs and Risk of High-Grade Cervical Dysplasia and Cervical Cancer in Rheumatoid Arthritis: A Cohort Study.

Authors:  Seoyoung C Kim; Sebastian Schneeweiss; Jun Liu; Elizabeth W Karlson; Jeffrey N Katz; Sarah Feldman; Daniel H Solomon
Journal:  Arthritis Rheumatol       Date:  2016-09       Impact factor: 10.995

6.  Prevalence of cervical human papillomavirus infection in women with systemic lupus erythematosus.

Authors:  Leomar D C Lyrio; Maria Fernanda R Grassi; Iuri U Santana; Viviana G Olavarria; Aline do N Gomes; Licia CostaPinto; Rone Peterson C Oliveira; Rita de Cássia R Aquino; Mittermayer B Santiago
Journal:  Rheumatol Int       Date:  2012-03-27       Impact factor: 2.631

7.  Cervical neoplasia in systemic lupus erythematosus: a nationwide study.

Authors:  Hjalmar Wadström; Elizabeth V Arkema; Christopher Sjöwall; Johan Askling; Julia F Simard
Journal:  Rheumatology (Oxford)       Date:  2017-04-01       Impact factor: 7.580

8.  Should we target patients with autoimmune diseases for human papillomavirus vaccine uptake?

Authors:  Candace H Feldman; Seoyoung C Kim
Journal:  Expert Rev Vaccines       Date:  2014-06-17       Impact factor: 5.217

Review 9.  Malignancies in systemic lupus erythematosus.

Authors:  Emese Kiss; Laszlo Kovacs; Peter Szodoray
Journal:  Autoimmun Rev       Date:  2009-07-27       Impact factor: 9.754

Review 10.  Skin cancer in organ transplant recipients: more than the immune system.

Authors:  Lee Wheless; Sarah Jacks; Kathryn Anne Mooneyham Potter; Brian C Leach; Joel Cook
Journal:  J Am Acad Dermatol       Date:  2014-04-13       Impact factor: 11.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.